Skip to main content
Pierre Triozzi, MD, Oncology, Winston Salem, NC

PierreLorenzoTriozziMD

Oncology Winston Salem, NC

Professor, Hematology & Oncology Cancer Biology Wake Forest Baptist Medical Center

Are you Dr. Triozzi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 79 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    S Hawthorne Rd
    Winston Salem, NC 27157
    Phone+1 336-716-2255

Summary

  • Dr. Pierre Triozzi, MD is an oncologist in Winston Salem, North Carolina. He is currently licensed to practice medicine in North Carolina, Alabama, and Ohio. He is affiliated with Atrium Wake Forest Baptist and is a Professor at Hematology & Oncology Cancer Biology Wake Forest Baptist Medical Center.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1983 - 1986
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1980 - 1983
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1980

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1980 - 2025
  • OH State Medical License
    OH State Medical License 1986 - 2025
  • AL State Medical License
    AL State Medical License 2000 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • CD138 Plasma Cells May Predict Brain Metastasis Recurrence Following Resection and Stereotactic Radiosurgery
    CD138 Plasma Cells May Predict Brain Metastasis Recurrence Following Resection and Stereotactic RadiosurgeryOctober 7th, 2019

Grant Support

  • Uveal Melanoma MicrometastasisNational Cancer Institute2009–2010
  • Aav-Based Plasmacytoid Dendritic Cell Cancer VaccineNational Cancer Institute2006–2010
  • Intratumoral Dendritic Cells PLUS Interleukin-2National Cancer Institute2001–2002
  • Cellular Immunotherapy Of HIV Infection Using Autologous Lymph NodesNational Center For Research Resources1997–2001
  • Chimeric HER-2 Peptide VaccineNational Cancer Institute2000
  • Chimeric HER-2 Peptide VaccineNational Cancer Institute1999–2000
  • Antigen Pulsed Dendritic Cell ImmunotherapyNational Cancer Institute1995–1997
  • Phase IB Trial Of IL-2 Alone Or With Cytotoxic CellsDivision Of Cancer Treatment1991–1993